No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-03-12
DOI
https://doi.org/10.3324/haematol.2025.300199
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study

Margaux Lafaurie, G. Moulis, Yoann Zadro, Maryse Lapeyre-Mestre et al.
Haematologica
Platelet Disorders and Treatments
article

No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study

Margaux Lafaurie, G. Moulis, Yoann Zadro, Maryse Lapeyre-Mestre, Agnès Sommet
article en

Abstract

No abstract available for this paper.
Haematologica
Université Fédérale de Toulouse Midi-Pyrénées (FR)
Amgen, Sanofi, CSL Behring, Argenx, Université de Toulouse, Swedish Orphan Biovitrum, Grifols
Good health and well-being
Openalex Percentile: Top 24%
Platelet Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.